Our Featured Experts

Peter Martin, MD
Dr. Martin on Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL
Peter Martin, MD, assistant professor of medicine in the Division of Hematology/Oncology at Weill Cornell Medical College, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses a trial of the combination of oral azacitidine (CC-486) and R-CHOP in diffuse large B-cell lymphoma (DLBCL).
Axel Hoos, MD, PhD
Oncology Specialists
Publication Bottom Border
Border Publication